Peer Review, UGC Care
IMPORTANCE OF ROLE OF PHARMACIST MEDIATED ADHERENCE IN HYPERTENSIVE PATIENTS A BRIEF OVERVIEW
View PDF

Keywords

Adherence, Hypertension, Antihypertensives, Nonadherence, Compliance.

How to Cite

Biradar, S. S. ., Kapatae, . R. ., Reddy, S. ., & S. A. Raju. (2012). IMPORTANCE OF ROLE OF PHARMACIST MEDIATED ADHERENCE IN HYPERTENSIVE PATIENTS A BRIEF OVERVIEW. International Journal of Research and Development in Pharmacy & Life Sciences, 1(1), 11-15. Retrieved from https://ijrdpl.com/index.php/ijrdpl/article/view/152

Abstract

Hypertension is an important risk factor for cardiovascular disease, the incidence of which it is possible to reduce by prophylactic treatment with antihypertensive drugs. Adherence to long-term therapies for chronic diseases in developed countries averages only 50%. In developing countries the rate is even lower, probably reflecting inequalities of access to appropriate health care facilities, supervised by qualified health care professionals. In clinical practice, however, only a minority of patients reach target blood pressure levels. The resulting gap between actual and potential health gains has been attributed to the fact that many patients do not take prescribed treatment as recommended. Pharmacists can play important roles in helping their patients with high blood pressure manage their condition. Serving as a partner and coach, pharmacists can provide medication therapy management services, educate patients about Hypertension. Further Pharmacists, physicians and other healthcare professionals should regard patients as partners in all decisions on treatments involving medication.

View PDF

References

http://www.who.int/cardiovascular_diseases/resources/atlas/en/. The Atlas of Heart Disease and Stroke. In: World Health Organization Health Topics; 2004.

Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003;289(19):2534-44.

Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26(1):60-9.

Koopmans RP, Insel PA, Michel MC. Pharmacogenetics of hypertension treatment: a structured review. Pharmacogenetics 2003;13 (12): 705-13.

Waeber B, Burnier M, Brunner HR. How to improve adherence with prescribed treatment inhypertensive patients. J Cardiovasc Pharmacol 2000;35 Suppl 3:S23-6.

Nell H, Louw CM, Cyster H, Williams Z, Bardin PG, Joubert JR. Therapeutic equivalence study of two formulations (innovator v. generic) of beclomethasone dipropionate in adult asthmatic patients. S Afr Med J 2001; 91(1):51-6.

Burnier M, Brunner HR. Impact on clinical outcomes. Compliance in healthcare and research.Monograph series.Armonk, NY, Blackwell, 2001:299–309.

Webb DG, Horne R, Pinching AJ.Treatment-related empowerment: preliminary evaluation of a new measure in patients with advanced HIV disease. Int J of STD & AIDS, 2001, 12:103-107.

Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167: 540-550.

Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21(11):1983-92.

Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Bloodpressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335 (8693):827-38.

Kjellgren KI, Ahlner J, Dahlöf B, Gill H, Hedner T, Säljö R. Patients’ and physicians’ assessment of risks associated with hypertension and benefits from treatment. J Cardiovasc Risk 1998;5 (3):161-6.

Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289 (18):2363-9.

Jones DW, Appel LJ, Sheps SG, Roccella EJ, Lenfant C. Measuring blood pressure accurately: new and persistent challenges. JAMA 2003;289(8):1027-30.

Himmelmann A, Hansson L, Hedner T. Blood pressure measurement: a century of achievements and improvements in the year 2002. Blood Press 2002;11(6):325-7.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (2004).

Morgan M, Watkins C. Managing hypertension – beliefs and responses to medication among cultural groups. Sociology of Health & Illness 1988;10(4):561-78.

Verdecchia P, O’Brien E, Pickering T, Staessen JA, Parati G, Myers M, et al. When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Am J Hypertens 2003;16(1):87-91

Appel, LJ, Brands, MW, Daniels, SR, Karanja, N, Elmer, PJ & Sacks, FW.. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2000:647:296-308.

Greeff, D. An approach to preventing and treating hypertension through lifestyle modification. Professional Nursing Today 2006.: 10(5): 8-22.

Xin, X, He, J, Frontini, MG, Ogden, LG, Motsamai, OI & Whelton, PK.. Effects of alcohol reduction on blood pressure: a meta-analysis of randomised controlled trials. Hypertension 2001:38(5): 1112-1117.

WHO. 2005. Country Cooperation Strategy Seychelles 2004-2007. Brazzaville: WHO Regional Office for Africa.

Campbell, NR, Petrella, R & Kaczorowski, J. 2006. Public education on hypertension: a new initiative to improve the prevention, treatment and control of hypertension in Canada. Canadian Journal of Cardiology 22(7):599-603.

Lahdenpera, TN & Kyngas, HA. 2000. Review: compliance and its evaluation in patients with hypertension. International Journal of Clinical Nursing 9 (6): 826-833.

Lewanczuk, R. 2006. Innovations in primary care: implications for hypertension detection and treatment. Canadian Journal of Cardiology 22(7): 614-616.

Kaplan, MN. 2005. Kaplan's clinical hypertension; 9th edition. Philadelphia: Lippincott Williams & Wilkins.

Morgado MP, Morgado SR, Mendes LC, et al. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm. 2011;68:241-253.

JNC 7th report Express. JAMA. 2003 Sep 10; 290(10):1314.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Copyright (c) 2020 Array

Downloads

Download data is not yet available.